understanding cholesterol effects of adalimumab by new techniques was another goal of gelfand and mehta's study..
the publication’s purpose is to be a "force for good and a platform for much needed change and to generate critical debate".. january 2010 (17)."we had (borrelia miyamotoi) as the new disease for the physicians to be aware of", told rusk.. february 2005 (8)..
"we had (borrelia miyamotoi) as the new disease for the physicians to be aware of", told rusk.. february 2005 (8)..